This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
NovaGold Resources (AMEX:NG) explores and develops mineral properties in North America. NG also gets an F in Equity. Shares of the stock have declined 45.2% since January 1. For more information, get Portfolio Grader’s complete analysis of NG stock.
Progenics Pharmaceuticals (NASDAQ:PGNX) develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. PGNX also gets F’s in Earnings Growth, Earnings Momentum, Analyst Earnings Revisions, Equity, and Cash Flow. Shares of the stock have declined 49.8% since January 1. This is worse than the Nasdaq, which has seen a 17.8% increase over the same period. For more information, get Portfolio Grader’s complete analysis of PGNX stock.
AVEO (NASDAQ:AVEO) engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. AVEO also gets F’s in Earnings Momentum, Equity, Cash Flow, and Operating Margin Growth. Since January 1, AVEO has fallen 44.8%. For more information, get Portfolio Grader’s complete analysis of AVEO stock.
Green Bankshares (NASDAQ:GRNB) is the holding company for Greene County Bank and Cumberland Bank. GRNB also gets an F in Earnings Momentum. For more information, get Portfolio Grader’s complete analysis of GRNB stock.
Aixtron (NASDAQ:AIXG) provides deposition equipment, such as that used in lighting, fiber optic communication systems, and mobile telephone applications, to the semiconductor industry. AIXG gets F’s in Earnings Growth, Earnings Momentum, Analyst Earnings Revisions, Equity, and Operating Margin Growth as well. For more information, get Portfolio Grader’s complete analysis of AIXG stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
